Nantahala Capital Management, LLC 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Nantahala Capital Management, LLC disclosed 131 US equity positions worth $1.6bn in its Q3 2025 13F filing. The largest position was ESTA at 5.0% of the reported book, followed by HGV and TBBK. Against the Q2 2025 filing, it opened 6 new positions, added to 13 and reduced 17 among the top 50 holdings.
What did Nantahala Capital Management, LLC own in Q3 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 5.0% | $80.9m | 1,973,492 | 11% | added |
| 2 | HGV HILTON GRAND VACATIONS INC | Consumer Cyclical | 4.3% | $69.7m | 1,667,753 | -16% | reduced |
| 3 | TBBK BANCORP INC DEL | Financial Services | 3.9% | $63.8m | 852,334 | -12% | reduced |
| 4 | QURE UNIQURE NV | 3.6% | $58.8m | 1,007,492 | -51% | reduced | |
| 5 | SLNOEUR SOLENO THERAPEUTICS INC | 3.6% | $58.4m | 863,763 | -14% | reduced | |
| 6 | ABVX ABIVAX SA | 2.9% | $47.3m | 557,564 | -62% | reduced | |
| 7 | XTNT XTANT MED HLDGS INC | 2.7% | $44.4m | 68,394,000 | 0% | held | |
| 8 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 2.7% | $43.0m | 4,670,784 | 9% | added |
| 9 | AMRX AMNEAL PHARMACEUTICALS INC | Healthcare | 2.6% | $42.3m | 4,224,564 | -3% | reduced |
| 10 | BVS BIOVENTUS INC | Healthcare | 2.4% | $38.9m | 5,810,662 | 10% | added |
| 11 | EOLS EVOLUS INC | Healthcare | 2.2% | $35.2m | 5,726,857 | 36% | added |
| 12 | PTON PELOTON INTERACTIVE INC | Consumer Cyclical | 2.1% | $33.3m | 3,697,700 | 13% | added |
| 13 | IMAX IMAX CORP | Communication Services | 2.0% | $32.6m | 996,150 | -12% | reduced |
| 14 | SVRA SAVARA INC | Healthcare | 1.9% | $31.3m | 8,775,375 | 5% | added |
| 15 | ETON ETON PHARMACEUTICALS INC | 1.6% | $25.6m | 1,175,951 | 0% | held | |
| 16 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 1.5% | $24.1m | 4,564,665 | 4% | added |
| 17 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.5% | $23.8m | 418,522 | -41% | reduced |
| 18 | COGT COGENT BIOSCIENCES INC | Healthcare | 1.3% | $21.6m | 1,506,989 | -9% | reduced |
| 19 | KROS KEROS THERAPEUTICS INC | Healthcare | 1.2% | $19.5m | 1,233,189 | -24% | reduced |
| 20 | GUTS FRACTYL HEALTH INC | 1.2% | $19.3m | 12,136,917 | – | new | |
| 21 | SERVICE PPTYS TR | 1.2% | $19.1m | 7,057,887 | -12% | reduced | |
| 22 | IRON DISC MEDICINE INC | Healthcare | 1.2% | $19.0m | 287,800 | 0% | held |
| 23 | CRMT AMERICAS CAR-MART INC | 1.2% | $18.8m | 644,686 | 0% | held | |
| 24 | ZVRA ZEVRA THERAPEUTICS INC | 1.2% | $18.8m | 1,971,936 | 34% | added | |
| 25 | TITN TITAN MACHY INC | Industrials | 1.1% | $18.4m | 1,096,232 | -3% | reduced |
| 26 | RMR RMR GROUP INC | 1.1% | $18.1m | 1,147,902 | 0% | held | |
| 27 | FOXF FOX FACTORY HLDG CORP | Consumer Cyclical | 1.1% | $17.7m | 728,648 | 0% | held |
| 28 | EB4 EVENTBRITE INC | 1.1% | $17.2m | 6,831,395 | 7% | added | |
| 29 | GMED GLOBUS MED INC | Healthcare | 1.1% | $17.2m | 300,000 | – | new |
| 30 | RAPT RAPT THERAPEUTICS INC | 1.0% | $16.1m | 623,282 | -35% | reduced | |
| 31 | AVTX AVALO THERAPEUTICS INC | Healthcare | 1.0% | $15.7m | 1,235,000 | 24% | added |
| 32 | PVLA PALVELLA THERAPEUTICS INC NE | 1.0% | $15.7m | 250,062 | 0% | held | |
| 33 | FLWS 1 800 FLOWERS COM INC | Consumer Cyclical | 1.0% | $15.5m | 3,368,065 | 68% | added |
| 34 | TNGX TANGO THERAPEUTICS INC | Healthcare | 0.9% | $15.2m | 1,809,948 | -47% | reduced |
| 35 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 0.9% | $14.8m | 375,000 | – | new |
| 36 | RDNW RIDENOW GROUP INC | 0.9% | $14.4m | 3,272,845 | 0% | held | |
| 37 | AURA AURA BIOSCIENCES INC | 0.8% | $13.1m | 2,117,697 | 0% | held | |
| 38 | XNCR XENCOR INC | Healthcare | 0.8% | $12.9m | 1,100,000 | 34% | added |
| 39 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 0.8% | $12.7m | 935,684 | -68% | reduced |
| 40 | GERN GERON CORP | Healthcare | 0.8% | $12.4m | 9,025,000 | – | new |
| 41 | JACK JACK IN THE BOX INC | Consumer Cyclical | 0.7% | $11.9m | 600,000 | 0% | held |
| 42 | BENITEC BIOPHARMA INC | 0.7% | $11.8m | 838,095 | 0% | held | |
| 43 | VSTM VERASTEM INC | Healthcare | 0.7% | $11.4m | 1,292,903 | -56% | reduced |
| 44 | UPB UPSTREAM BIO INC | 0.7% | $11.2m | 594,971 | 0% | held | |
| 45 | LB PHARMACEUTICALS INC | 0.7% | $10.7m | 675,000 | – | new | |
| 46 | SLDB SOLID BIOSCIENCES INC | Healthcare | 0.6% | $10.5m | 1,699,258 | -0% | held |
| 47 | JCAP JEFFERSON CAPITAL INC | 0.6% | $10.4m | 600,000 | 0% | held | |
| 48 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 0.6% | $10.3m | 368,553 | 119% | added |
| 49 | MDXG MIMEDX GROUP INC | Healthcare | 0.6% | $10.2m | 1,466,566 | – | new |
| 50 | CMPS COMPASS PATHWAYS PLC | Healthcare | 0.6% | $9.9m | 1,729,930 | -59% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.